Carlos Vallejo

3.3k total citations
118 papers, 2.0k citations indexed

About

Carlos Vallejo is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Hematology. According to data from OpenAlex, Carlos Vallejo has authored 118 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Oncology, 29 papers in Pulmonary and Respiratory Medicine and 26 papers in Hematology. Recurrent topics in Carlos Vallejo's work include Hematopoietic Stem Cell Transplantation (21 papers), Breast Cancer Treatment Studies (18 papers) and Antifungal resistance and susceptibility (15 papers). Carlos Vallejo is often cited by papers focused on Hematopoietic Stem Cell Transplantation (21 papers), Breast Cancer Treatment Studies (18 papers) and Antifungal resistance and susceptibility (15 papers). Carlos Vallejo collaborates with scholars based in United States, Spain and Argentina. Carlos Vallejo's co-authors include M. Machiavelli, J. Eduardo Pérez, Bernardo Amadeo Leone, J. Lacava, José Pablo Leone, Julieta Leone, A. Romero, B Leone, Maria Cuevas and Michael R. Loken and has published in prestigious journals such as Journal of Clinical Oncology, Blood and JNCI Journal of the National Cancer Institute.

In The Last Decade

Carlos Vallejo

111 papers receiving 2.0k citations

Peers

Carlos Vallejo

ONCOL

HEMAT

PRM

PHEOH

W. P. Peters United States

Michel Symann Belgium

Johannes Blom Sweden

Stuart L. Goldberg United States

Pietro Muretto Italy

Sang Kyun Sohn South Korea

M. Flesch France

Peter A. Daly Ireland

John Ellerton United States

Byron M. Espina United States

W. P. Peters United States

Carlos Vallejo

1.1k ×1.1

ONCOL

620 ×1.2

HEMAT

521 ×1.4

254 ×0.7

PRM

137 ×0.5

PHEOH

Citations per year, relative to Carlos Vallejo Carlos Vallejo (= 1×) peers W. P. Peters

Countries citing papers authored by Carlos Vallejo

Since Specialization

Citations

This map shows the geographic impact of Carlos Vallejo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carlos Vallejo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carlos Vallejo more than expected).

Fields of papers citing papers by Carlos Vallejo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carlos Vallejo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carlos Vallejo. The network helps show where Carlos Vallejo may publish in the future.

Co-authorship network of co-authors of Carlos Vallejo

This figure shows the co-authorship network connecting the top 25 collaborators of Carlos Vallejo. A scholar is included among the top collaborators of Carlos Vallejo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carlos Vallejo. Carlos Vallejo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Leone, José Pablo, Julieta Leone, Faina Nakhlis, et al.. (2024). Survival outcomes and treatment patterns by tumor subtype (TS) in stage III inflammatory and non-inflammatory breast cancer (BC).. Journal of Clinical Oncology. 42(16_suppl). 607–607. 1 indexed citations

Scheinberg, Phillip, Carlo Finelli, Carlos Vallejo, et al.. (2024). Activity and safety of eltrombopag in combination with cyclosporin A as first‑line treatment of adults with severe aplastic anaemia (SOAR): a phase 2, single-arm study. The Lancet Haematology. 11(3). e206–e215. 7 indexed citations

Leone, José Pablo, Noah Graham, Sara M. Tolaney, et al.. (2023). Estimating mortality in women with triple-negative breast cancer: The ‘ESTIMATE triple-negative’ tool. European Journal of Cancer. 189. 112930–112930. 2 indexed citations

Leone, José Pablo, Noah Graham, Sara M. Tolaney, et al.. (2022). Estimating long-term mortality in women with hormone receptor-positive breast cancer: The ‘ESTIMATE’ tool. European Journal of Cancer. 173. 20–29. 4 indexed citations

Leone, José Pablo, Michael J. Hassett, Julieta Leone, et al.. (2022). Efficacy of neoadjuvant chemotherapy in male breast cancer compared with female breast cancer. Cancer. 128(21). 3796–3803. 8 indexed citations

Leone, José Pablo, Bernardo Amadeo Leone, Nabihah Tayob, et al.. (2021). Twenty-year risks of breast cancer-specific mortality for stage III breast cancer in the surveillance, epidemiology, and end results registry. Breast Cancer Research and Treatment. 187(3). 843–852. 9 indexed citations

Leone, José Pablo, Carlos Vallejo, Michael J. Hassett, et al.. (2021). Factors associated with late risks of breast cancer-specific mortality in the SEER registry. Breast Cancer Research and Treatment. 189(1). 203–212. 16 indexed citations

Leone, Julieta, Rachel A. Freedman, Nancy U. Lin, et al.. (2021). Tumor subtypes and survival in male breast cancer. Breast Cancer Research and Treatment. 188(3). 695–702. 22 indexed citations

Leone, José Pablo, Carlos Vallejo, Michael J. Hassett, et al.. (2021). Correction to: Factors associated with late risks of breast cancer‑specific mortality in the SEER registry. Breast Cancer Research and Treatment. 189(1). 305–305. 2 indexed citations

10.

Bacigalupo, Andrea, Rosi Oneto, Hubert Schrezenmeier, et al.. (2018). First line treatment of aplastic anemia with thymoglobuline in Europe and Asia: Outcome of 955 patients treated 2001‐2012. American Journal of Hematology. 93(5). 643–648. 34 indexed citations

11.

Gallardo, David, Rocío Rodriguez, Ismael Buño, et al.. (2017). Donor CTLA-4 Genotype Modulates the Immune Response to Minor Histocompatibility Antigen Mismatches. Biology of Blood and Marrow Transplantation. 23(12). 2042–2047. 4 indexed citations

12.

Leone, José Pablo, et al.. (2016). Locoregional treatment and overall survival of men with T1a,b,cN0M0 breast cancer: A population-based study. European Journal of Cancer. 71. 7–14. 32 indexed citations

13.

Leone, José Pablo, et al.. (2015). Prognostic significance of tumor subtypes in male breast cancer: a population-based study. Breast Cancer Research and Treatment. 152(3). 601–609. 35 indexed citations

14.

Vallejo, Carlos, Lourdes Vázquez, Enric Carreras, et al.. (2013). Tratamiento de las infecciones fúngicas invasoras en pacientes hematológicos de alto riesgo: ¿Qué hemos aprendido en los pasados 10 años?. Revista española de quimioterapia. Suplemento. 26(4). 378–386. 2 indexed citations

15.

Jarque, Isidro, Javier López Jiménez, M. Jurado, et al.. (2013). Tratamiento de infecciones fúngicas en pacientes hematológicos de alto riesgo. La respuesta de AmBisome no se modifica con el uso previo de azoles de amplio espectro. Revista española de quimioterapia. Suplemento. 26(1). 64–69. 3 indexed citations

16.

Vallejo, Carlos, et al.. (2011). Tratamiento antifúngico empírico: una alternativa válida para la infección fúngica invasora. Revista española de quimioterapia. Suplemento. 24(3). 117–122. 4 indexed citations

17.

Vallejo, Carlos. (2008). Effectiveness of Itraconazole as Prophylaxis of Invasive Fungal Infection (IFI) in Neutropenic Patients with Haematological Malignancies. 46th Annual Meeting. 1 indexed citations

18.

Vallejo, Carlos, et al.. (2007). Aleteo auricular neonatal. Archivos Argentinos de Pediatria. 105(5). 427–429. 2 indexed citations

19.

Carreras, Enric, Mónica Jiménez, Rafael de la Cámara, et al.. (2005). Donor age and degree of HLA matching have a major impact on the outcome of unrelated donor haematopoietic cell transplantation for chronic myeloid leukaemia. Bone Marrow Transplantation. 37(1). 33–40. 44 indexed citations

20.

Moróte, Juan, et al.. (1995). [Final results of complete hormone blockade versus monotherapy in prostatic metastatic cancer. PSA implications].. PubMed. 19(8). 604–10. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact